Prosperity Consulting Group LLC lessened its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 62.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,887 shares of the conglomerate's stock after selling 3,142 shares during the quarter. Prosperity Consulting Group LLC's holdings in Danaher were worth $387,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of the business. GAMMA Investing LLC boosted its holdings in shares of Danaher by 24,958.2% in the 1st quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock valued at $383,524,000 after purchasing an additional 1,863,381 shares in the last quarter. Two Sigma Advisers LP boosted its holdings in shares of Danaher by 4,248.8% in the 4th quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock valued at $376,347,000 after purchasing an additional 1,601,800 shares in the last quarter. Capital World Investors boosted its holdings in shares of Danaher by 32.7% in the 4th quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock valued at $1,460,215,000 after purchasing an additional 1,566,658 shares in the last quarter. Point72 Asset Management L.P. boosted its holdings in shares of Danaher by 460.6% in the 4th quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate's stock valued at $309,558,000 after purchasing an additional 1,107,998 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Danaher in the 4th quarter valued at $242,837,000. Institutional investors and hedge funds own 79.05% of the company's stock.
Insider Activity at Danaher
In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman owned 3,105,808 shares of the company's stock, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 11.10% of the stock is currently owned by corporate insiders.
Danaher Stock Down 0.0%
Shares of DHR traded down $0.08 during trading hours on Friday, hitting $197.08. The stock had a trading volume of 5,736,543 shares, compared to its average volume of 4,375,955. The firm has a market capitalization of $141.12 billion, a P/E ratio of 41.93, a price-to-earnings-growth ratio of 2.74 and a beta of 0.73. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.90. The firm has a 50 day simple moving average of $197.49 and a 200-day simple moving average of $202.68.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The company's quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.72 EPS. Sell-side analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, July 25th. Shareholders of record on Friday, June 27th were given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher's dividend payout ratio is currently 27.23%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on DHR shares. Scotiabank raised Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price on the stock in a report on Friday, July 11th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $250.00 price target on shares of Danaher in a research note on Wednesday, April 23rd. Wolfe Research dropped their price target on Danaher from $275.00 to $220.00 and set an "outperform" rating for the company in a research note on Monday, April 7th. The Goldman Sachs Group dropped their price target on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. Finally, Evercore ISI dropped their price target on Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Three analysts have rated the stock with a hold rating and eighteen have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $247.61.
Read Our Latest Analysis on DHR
About Danaher
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
MarketBeat All Access